Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Karlgren

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pharmaceutical Research|August 24, 2011
In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactionsMaria Karlgren, Gustav Ahlin, Christel A S Bergström, et al.
Pharmacogenomics|November 6, 2007
Expression of CYP2W1 in colon tumors: regulation by gene methylationAlvin Gomez, Maria Karlgren, David Edler, et al.
Drug News & Perspectives|January 13, 2005
New approaches and applications in chemical biologyAlvin Gomez, Magnus Ingelman-Sundberg, Inger Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2009
The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer - a pilot studyDavid Edler, Kristina Stenstedt, Katarina Ohrling, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 5, 2016
Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up ApproachAnna Vildhede, André Mateus, Elin K Khan, et al.
Journal of Pharmaceutical Sciences|February 13, 2016
Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9Ivailo Simoff, Maria Karlgren, Maria Backlund, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 7, 2014
Hepatic uptake of atorvastatin: influence of variability in transporter expression on uptake clearance and drug-drug interactionsAnna Vildhede, Maria Karlgren, Elin K Svedberg, et al.
Journal of Medicinal Chemistry|May 1, 2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactionsMaria Karlgren, Anna Vildhede, Ulf Norinder, et al.
ACS Chemical Neuroscience|May 3, 2021
Integration of Mass Spectrometry Imaging and Machine Learning Visualizes Region-Specific Age-Induced and Drug-Target Metabolic Perturbations in the BrainTheodosia Vallianatou, Reza Shariatgorji, Anna Nilsson, et al.
Molecular Pharmaceutics|September 28, 2019
The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling ApproachIrina E Antonescu, Karina F Rasmussen, Sibylle Neuhoff, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pharmaceutical Research|August 24, 2011
In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactionsMaria Karlgren, Gustav Ahlin, Christel A S Bergström, et al.
Pharmacogenomics|November 6, 2007
Expression of CYP2W1 in colon tumors: regulation by gene methylationAlvin Gomez, Maria Karlgren, David Edler, et al.
Drug News & Perspectives|January 13, 2005
New approaches and applications in chemical biologyAlvin Gomez, Magnus Ingelman-Sundberg, Inger Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2009
The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer - a pilot studyDavid Edler, Kristina Stenstedt, Katarina Ohrling, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 5, 2016
Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up ApproachAnna Vildhede, André Mateus, Elin K Khan, et al.
Journal of Pharmaceutical Sciences|February 13, 2016
Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9Ivailo Simoff, Maria Karlgren, Maria Backlund, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 7, 2014
Hepatic uptake of atorvastatin: influence of variability in transporter expression on uptake clearance and drug-drug interactionsAnna Vildhede, Maria Karlgren, Elin K Svedberg, et al.
Journal of Medicinal Chemistry|May 1, 2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactionsMaria Karlgren, Anna Vildhede, Ulf Norinder, et al.
ACS Chemical Neuroscience|May 3, 2021
Integration of Mass Spectrometry Imaging and Machine Learning Visualizes Region-Specific Age-Induced and Drug-Target Metabolic Perturbations in the BrainTheodosia Vallianatou, Reza Shariatgorji, Anna Nilsson, et al.
Molecular Pharmaceutics|September 28, 2019
The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling ApproachIrina E Antonescu, Karina F Rasmussen, Sibylle Neuhoff, et al.
Pageof 3